100 related articles for article (PubMed ID: 33892849)
61. [Leukodystrophies: clinical aspects and findings with computerized tomography and magnetic resonance imaging].
Magnaldi S
Radiol Med; 1991; 82(1-2):13-26. PubMed ID: 1896564
[TBL] [Abstract][Full Text] [Related]
62. Astroglia in Leukodystrophies.
Jorge MS; Bugiani M
Adv Exp Med Biol; 2019; 1175():199-225. PubMed ID: 31583590
[TBL] [Abstract][Full Text] [Related]
63. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
[TBL] [Abstract][Full Text] [Related]
64. Diagnosis, prognosis, and treatment of leukodystrophies.
van der Knaap MS; Schiffmann R; Mochel F; Wolf NI
Lancet Neurol; 2019 Oct; 18(10):962-972. PubMed ID: 31307818
[TBL] [Abstract][Full Text] [Related]
65. Transplant outcomes in leukodystrophies.
Orchard PJ; Tolar J
Semin Hematol; 2010 Jan; 47(1):70-8. PubMed ID: 20109614
[TBL] [Abstract][Full Text] [Related]
66. Case definition and classification of leukodystrophies and leukoencephalopathies.
Vanderver A; Prust M; Tonduti D; Mochel F; Hussey HM; Helman G; Garbern J; Eichler F; Labauge P; Aubourg P; Rodriguez D; Patterson MC; Van Hove JL; Schmidt J; Wolf NI; Boespflug-Tanguy O; Schiffmann R; van der Knaap MS;
Mol Genet Metab; 2015 Apr; 114(4):494-500. PubMed ID: 25649058
[TBL] [Abstract][Full Text] [Related]
67. Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.
Phelan JA; Lowe LH; Glasier CM
Pediatr Radiol; 2008 Jul; 38(7):729-49. PubMed ID: 18446335
[TBL] [Abstract][Full Text] [Related]
68. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment.
Berger J; Moser HW; Forss-Petter S
Curr Opin Neurol; 2001 Jun; 14(3):305-12. PubMed ID: 11371752
[TBL] [Abstract][Full Text] [Related]
69. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.
van Rappard DF; Boelens JJ; Wolf NI
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):261-73. PubMed ID: 25987178
[TBL] [Abstract][Full Text] [Related]
70. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.
Adang LA; Sherbini O; Ball L; Bloom M; Darbari A; Amartino H; DiVito D; Eichler F; Escolar M; Evans SH; Fatemi A; Fraser J; Hollowell L; Jaffe N; Joseph C; Karpinski M; Keller S; Maddock R; Mancilla E; McClary B; Mertz J; Morgart K; Langan T; Leventer R; Parikh S; Pizzino A; Prange E; Renaud DL; Rizzo W; Shapiro J; Suhr D; Suhr T; Tonduti D; Waggoner J; Waldman A; Wolf NI; Zerem A; Bonkowsky JL; Bernard G; van Haren K; Vanderver A;
Mol Genet Metab; 2017 Sep; 122(1-2):18-32. PubMed ID: 28863857
[TBL] [Abstract][Full Text] [Related]
71. Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines.
Chatterjee S; Sivanandam V; Wong KK
Hum Gene Ther; 2020 May; 31(9-10):542-552. PubMed ID: 32253938
[TBL] [Abstract][Full Text] [Related]
72. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
Parikh S; Bernard G; Leventer RJ; van der Knaap MS; van Hove J; Pizzino A; McNeill NH; Helman G; Simons C; Schmidt JL; Rizzo WB; Patterson MC; Taft RJ; Vanderver A;
Mol Genet Metab; 2015 Apr; 114(4):501-515. PubMed ID: 25655951
[TBL] [Abstract][Full Text] [Related]
73. Lysosomal disorders associated with leukoencephalopathy.
Renaud DL
Semin Neurol; 2012 Feb; 32(1):51-4. PubMed ID: 22422206
[TBL] [Abstract][Full Text] [Related]
74. Emerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies.
von Jonquieres G; Rae CD; Housley GD
Front Cell Neurosci; 2021; 15():661857. PubMed ID: 34239416
[TBL] [Abstract][Full Text] [Related]
75. Juvenile metachromatic leukodystrophy: understanding the disease and implications for nursing care.
Barrell C
J Pediatr Oncol Nurs; 2007; 24(2):64-9. PubMed ID: 17332420
[TBL] [Abstract][Full Text] [Related]
76. Biochemical aspects of globoid and metachromatic leukodystrophies.
Farooqui AA; Horrocks LA
Neurochem Pathol; 1984; 2(3):189-218. PubMed ID: 6152665
[TBL] [Abstract][Full Text] [Related]
77. Developing treatment options for metachromatic leukodystrophy.
Batzios SP; Zafeiriou DI
Mol Genet Metab; 2012 Jan; 105(1):56-63. PubMed ID: 22078456
[TBL] [Abstract][Full Text] [Related]
78. Update on leukodystrophies and developing trials.
Ceravolo G; Zhelcheska K; Squadrito V; Pellerin D; Gitto E; Hartley L; Houlden H
J Neurol; 2024 Jan; 271(1):593-605. PubMed ID: 37755460
[TBL] [Abstract][Full Text] [Related]
79. [Pathogenesis and pathomorphology of human leukodystrophies].
Zhabotinskiĭ IuM; Shefer VF
Arkh Patol; 1981; 43(11):86-92. PubMed ID: 7032481
[TBL] [Abstract][Full Text] [Related]
80. Gene therapy of metachromatic leukodystrophy.
Matzner U; Gieselmann V
Expert Opin Biol Ther; 2005 Jan; 5(1):55-65. PubMed ID: 15709909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
